Restoring Independence
Neuvotion is developing AI-guided brain-body interface (BBI) and 3D (whole brain) brain-computer interface (BCI) technologies, defining a new category in medicine and revolutionizing neurorecovery. We are combining AI-guided neurostimulation at 10x resolution to unlock user potential. Our platform includes non and minimally-invasive body, spinal, and brain interfaces. Our body and 3D BCI technologies target a wide range of neurological conditions including stroke and spinal cord injury to restore function and independence.
Building on two decades of pioneering science and BCI/BBI technology development led by Prof. Chad Bouton, we are accelerating the deployment of neural bypass technology — a revolutionary approach that reconnects the brain and body to restore function while promoting and accelerating neurological recovery.
Neuvotion & NeuStim User Story
Core neural bypass science and technology has been validated in multiple clinical studies with the latest appearing on the cover of Nature Medicine. Neuvotion's first brain-body interface (BBI) platform product, NeuStim(R), is launching soon in US clinical settings.
Market Need
Recent Media
NBC - NeuStim & Brain-Body Interface restores strength and sense of touch (click below).
Growth
The U.S. Outpatient Rehabilitation/Physical Therapy market is more than $30 billion today with steady growth exceeding 5% annually.
(U.S. Physical Therapy, Inc.)
Clinical Collaboration
About Us
We are a highly experienced team with decades of experience in developing and commercializing groundbreaking technologies for unmet clinical needs. Our team is devoted to our mission of continually innovating, helping our users maximize their recovery, and disrupting the neurotechnology market. Contact us today to learn more.
Chad Bouton, PhD
Founder and CEO
30+ years in innovating & commercializing medical device technologies; >70 patents; Innovator of the Year 4x; BCI & BBI pioneer; Published in Nature
Rory Murphy, MD
Scientific Advisor
20+ years in spinal cord injury and advanced surgeries; Neurosurgeon at Barrow Neurosurgical Institute
​
Dave Jones
COO and Regulatory Lead
45+ years in medical device R&D, commercialization, business development, and regulatory affairs
Sandeep Singh, MD
Scientific Advisor
25+ years in medicine;
Expertise in stroke, SCI, movement disorders;
CMO, Good Shepherd Rehabilitation Services
Michael Spigel, PT, MHA
Strategy
30+ years in healthcare, rehabilitation, administration, executive leadership, and innovation.
Dan Sciubba, MD
Clinical Advisor
Formerly at Johns Hopkins, currently Chair of Neurosurgery at Northwell Health, 25+ years of experience, handling complex neurosurgeries and pioneering new and effective techniques
​